Kronox Lab Sciences growth over the years

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr2 yr
Revenue+1.0%+6.1%
EBITDA+3.5%+10.0%
Net Income+9.3%+13.8%
EPS (adj.)+9.3%+13.8%
Total Assets+29.1%+31.3%
Total Equity+28.9%+32.4%
Free Cash Flow−29.9%+100.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KRONOX₹194.73

Kronox Lab Sciences Limited

· Chemicals
₹ CrorePeersJAYAGROGNDMCCSRHHYPOLTDCHEMFABPRIMOPLASTIBLENGEMAROMASUDARCOLORMcap ₹723 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
2Y
CAGR
Revenue+1.0+6.1
EBITDA+3.5+10.0
Net Income+9.3+13.8
EPS (adj.)+9.3+13.8
Total Assets+29.1+31.3
Total Equity+28.9+32.4
Free Cash Flow-29.9+100.1
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.